First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosisStrong first half net sales...